Finance

Lists
MRK:ETR
Merck KGaA
€139.35
+0.25%
(+0.35) 1D
Oct 7, 3:42:37 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for MRK...
Open
€138.50
High
€141.10
Low
€137.50
Mkt. cap
18.15B
Avg. vol.
282.24K
Volume
64.79K
Dividend
1.58%
Quarterly dividend
€0.55
Ex-dividend date
Apr 27, 2026
P/E ratio
25.59
52-wk high
€148.80
52-wk low
€100.70
EPS
€5.45
Shares outstanding
129.24M
No. of employees
62K
Open
€138.50
High
€141.10
Low
€137.50
Mkt. cap
18.15B
Avg. vol.
282.24K
Volume
64.79K
Dividend
1.58%
Quarterly dividend
€0.55
Ex-dividend date
Apr 27, 2026
P/E ratio
25.59
52-wk high
€148.80
52-wk low
€100.70
EPS
€5.45
Shares outstanding
129.24M
No. of employees
62K
News stories
From web sources and news partners
Profile
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Shizuoka and Beijing, as well as other Research and Development units in Taiwan, France, Israel, South Korea, India, and the UK. Merck pioneered the commercial manufacture of morphine in the 19th century and for a time held a virtual monopoly on cocaine. Merck was privately owned until going public on the Frankfurt Stock Exchange in 1995 and is listed on the DAX index of Germany's top companies. The Merck family still controls a majority of 70.3% of the company's shares. Wikipedia
About Merck KGaA
CEO-
Employees62.1K
Founded1668
Headquarters-
SectorPharmaceutical industry
Websitemerckgroup.com
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (EUR)
€2.16 / €2.05
+5.32%beat
Revenue / Est. (EUR)
5.43B / 5.30B
+2.44%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.32B
5.25B
5.13B
5.43B
Cost of goods sold
2.10B
2.20B
2.07B
2.27B
Cost of revenue
2.10B
2.20B
2.07B
2.27B
Research and development expenses
660.00M
634.00M
657.70M
684.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.46B
1.54B
1.52B
1.56B
Operating expense
1.99B
2.12B
2.13B
2.41B
Total operating expenses
4.10B
4.32B
4.20B
4.68B
Operating income
1.22B
926.00M
935.40M
753.00M
Other non operating income
1.00M
4.00M
-100.00K
-1.00M
EBT including unusual items
1.12B
401.00M
868.70M
640.00M
EBT excluding unusual items
1.12B
1.10B
867.50M
640.00M
Income tax expense
225.00M
77.00M
200.00M
146.00M
Effective tax rate
20.04%
19.20%
23.02%
22.81%
Other operating expenses
-128.00M
-50.00M
-45.40M
164.00M
Net income
902.00M
319.00M
659.40M
490.00M
Net profit margin
16.96%
6.08%
12.84%
9.02%
Earnings per share
-
-
-
2.16
Interest and investment income
27.00M
21.00M
21.20M
25.00M
Interest expense
-126.00M
-43.00M
-80.60M
-137.00M
Net interest expenses
-99.00M
-22.00M
-59.40M
-112.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.68B
1.31B
1.42B
1.25B
Gain or loss from assets sale
-174.00M
6.00M
-41.90M
1.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps